Showing results (291-300 of 10,059) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|December 8, 2004
Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complicationsS CellekCurrent Pharmaceutical Design|December 8, 2004
Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone"Marie-Line AndréolaCurrent Pharmaceutical Design|December 8, 2004
Targeting the assembly of the human immunodeficiency virus type ID Muriaux, J L Darlix, A CimarelliCurrent Pharmaceutical Design|December 8, 2004
Picornavirus IRES: structure function relationshipEncarnación Martínez-Salas, Olga Fernández-MiragallCurrent Pharmaceutical Design|December 8, 2004
Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancerAoife Lacy, Richard O'KennedyCurrent Pharmaceutical Design|December 8, 2004
Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activitiesKonstantina C Fylaktakidou, Dimitra J Hadjipavlou-Litina, Konstantinos E Litinas, et al.Current Pharmaceutical Design|December 8, 2004
Analysis of fish IL-1beta and derived peptide sequences indicates conserved structures with species-specific IL-1 receptor binding: implications for pharmacological designAntonis I Koussounadis, David W Ritchie, Graham J L Kemp, et al.Current Pharmaceutical Design|December 8, 2004
Structural process and implementation programs of pharmaceutical care in different countriesM J Martín-Calero, M Machuca, M D Murillo, et al.Current Pharmaceutical Design|December 8, 2004
Antiviral drugs that target cellular proteins may play major roles in combating HIV resistanceVéronic Marie Isabelle Provencher, Ersilia Coccaro, Jonathan Jacques Lacasse, et al.Current Pharmaceutical Design|December 8, 2004
Current biological therapies for inflammatory bowel diseaseDaniel C Baumgart, Axel U DignassPageof 1,006